← All articles2026-05-18 · 8 min read

AI therapy apps: licensing rules, FTC enforcement, and the crisis-resources duty

Mental-health software has a regulatory stack that's deeper than founders usually realise. State psychology licensing boards police diagnosis and treatment claims. The FTC enforces against deceptive data-sharing. The FDA regulates anything that diagnoses or treats — even via chatbot. And both major app stores now require crisis-resources disclosure. Here's the enforcement record, the four-layer compliance stack, and what to ship before traffic scales.

The enforcement record so far

Multiple AI / chatbot mental-health products have been targets of recent enforcement. Each action shaped what the next generation of products needs to do at minimum.

$7.8M
BetterHelp FTC settlement (2023, data-sharing)
$5.1M
Cerebral FTC settlement (2024, prescribing + data)
$2.5M
Monument FTC settlement (2023, mental-health data sharing)
Italy
Replika banned (2023, minors + therapeutic claims)
  • BetterHelp (FTC, 2023) — settled $7.8M over sharing mental-health intake data with Meta, Snap, and others via pixels. The remediation included granular data-sharing disclosure prescriptions that became the template for the category.
  • Cerebral (FTC, 2024) — $5.1M settlement over prescribing controlled substances after light-touch online assessment and sharing patient data with advertising platforms.
  • Monument (FTC, 2023) — $2.5M for sharing user mental-health and alcohol-treatment data with ad networks.
  • Replika (Italian Garante, 2023) — banned in Italy for therapeutic claims and accessibility to minors without age verification or safeguards.
  • Woebot, Wysa, Calm, Headspace — operating without enforcement actions; all carry the disclaimer-plus-crisis-resources pattern described below.

Layer 1 — State licensing boards

Every US state regulates the practice of psychology, psychiatry, counseling, and clinical social work. The statutes use language written for human practitioners but state boards have consistently applied them to software products that perform the same functions. The operative test is whether the software diagnoses, treats, or provides psychotherapy. "Treatment" is the term-of-art most boards focus on — and it's broader than founders assume.

  • Diagnostic statements ("you have anxiety / depression / PTSD") are reserved to licensed clinicians in every state. Replace with experiential framing ("what you're describing is something many people associate with anxiety").
  • The words "therapy", "psychotherapy", "counseling" are state-board sensitive. Use "support", "reflection", "self-help" instead.
  • Prescription of psychiatric medication requires a licensed prescriber. Software-mediated prescribing (the Cerebral pattern) is what triggered FTC action.
  • Equivalence claims ("replaces your therapist", "AI therapist") have triggered Italian, German, and US state-board actions.

Layer 2 — FTC + state AGs

The FTC has pursued mental-health apps on two recurring theories: (1) deceptive marketing (overclaiming clinical efficacy or independence) and (2) inadequate data-sharing disclosure (sharing mental-health data with ad networks without granular consent). Both BetterHelp and Monument settlements turn on the second theory. The remediation language in those consent orders is now the de-facto compliance template for the category.

The BetterHelp template

The BetterHelp consent order requires the company to obtain affirmative express consent before sharing any health information for advertising, to provide granular disclosure of every category of data shared with each third party, and to pay $7.8M in consumer redress. The template — granular disclosure + affirmative consent + no behavioural advertising — is what subsequent settlements have replicated.

Layer 3 — FDA (sometimes)

The FDA regulates software as a medical device (SaMD) when the software is intended to diagnose, cure, mitigate, treat, or prevent disease. Most mental-health support apps stay out of FDA scope by carefully avoiding diagnostic and treatment claims. Apps that diagnose, recommend treatment, or claim to treat specific conditions enter SaMD scope and require either FDA clearance (510(k)) or enforcement discretion under FDA's digital health guidance.

Practical implication: language matters here at exactly the same place state-board law cares about it. The phrase "treats anxiety" pulls you into both unlicensed-practice and SaMD scope; "supports people experiencing anxiety" stays out of both.

Layer 4 — App store policies

Apple and Google both require crisis-resources disclosure for apps in the mental-health, wellness, and self-help categories. Rejection at app review is the most common operational consequence — the practical floor is to include 988 (US Suicide & Crisis Lifeline) in every app and on every web page that touches mental-health content.

The four-line minimum every survivor ships

  1. Crisis resources in the footer + in the chat interface header: "If you're in crisis, call or text 988 in the US, or visit findahelpline.com for international resources."
  2. Disclaimer next to every interaction: "I'm a self-reflection tool, not a therapist. I can't diagnose or treat conditions."
  3. Granular data-sharing disclosure on the home page and privacy policy: name every third party and exactly what category of data is shared with each.
  4. No diagnostic language in any model output. Train the system prompt against "you have X" framings. Comply Code's scanner flags these in your rendered HTML.

EU and UK overlay

If you serve EU users, the EU AI Act treats mental-health systems with care: standalone diagnostic / treatment systems are likely high-risk under Article 6 + Annex III, requiring conformity assessment. The UK's MHRA regulates software-as-a-medical-device on essentially the same lines as the FDA. GDPR's Article 9 also makes mental-health data "special category" requiring explicit consent — granular data-sharing disclosure is mandatory, not best-practice, in EU scope.

What to do this week

  1. Add 988 / findahelpline.com to your footer and chat header today. This satisfies both the duty-of-care argument and app-store review.
  2. Audit every user-facing string in your product for the words: diagnose, treat, prescribe, therapy, psychotherapy. Replace each.
  3. Document what mental-health data you share with every third party and write it into your home page in plain language — not buried in the privacy policy.
  4. Re-scan after each change. Comply Code's mental-health rule pack catches the disclaimer absences, diagnostic-language patterns, and missing crisis resources described here.
More: compliance scanning for AI therapy and mental-health apps

Common questions.

Is calling it an 'AI companion' instead of 'AI therapist' enough?

It helps but is not sufficient on its own. State boards and the FTC look at function, not just naming. A product called 'AI companion' that diagnoses anxiety and recommends treatment is still doing the regulated thing. The naming matters because it shapes user expectations and reduces marketing-deception risk; the underlying behaviour is what determines licensing-board exposure.

What if I just use the LLM with no clinical claims?

This is the safest framing and what most surviving products do. Position the product as a self-reflection or journaling aid, avoid clinical vocabulary, include the disclaimer and crisis resources, and make the system prompt actively avoid diagnostic outputs. This isn't a guarantee against state-board investigation but it's the established floor.

Do I need HIPAA compliance?

HIPAA applies if you're a 'covered entity' (insurer, provider, clearinghouse) or a 'business associate' of one. Most consumer-direct mental-health apps are not covered entities and don't trigger HIPAA. They DO trigger state mental-health privacy laws (which often have HIPAA-equivalent provisions for mental-health data specifically), Washington's My Health My Data Act, and FTC Section 5. Operationally, the BetterHelp consent order's data-sharing template is what most apps now use — it's strict enough to satisfy most overlapping regimes.

What about minors?

If your app is accessible to minors (under 18 in most US states, varies elsewhere), you face additional layers: COPPA (under 13 in the US) requires verifiable parental consent for data collection; the EU AI Act treats minors as a sensitive group warranting extra protection; and state-by-state rules on minor mental-health treatment apply. Most consumer mental-health products require users to confirm they're 18+ at signup specifically to stay out of this layer.

Does Comply Code's scanner detect mental-health licensing risk?

Yes — when our classifier detects mental-health vertical signals, it runs a rule pack flagging diagnostic language, missing 'not a substitute for professional care' disclaimers, missing crisis-resources disclosure, and undisclosed third-party data sharing. Findings appear under 'professional licensing' in the report.

Related reading.

Sources

Want to find out which of these apply to your app?

Paste your URL. 60 seconds. Free.

Scan your app →